Evaluation of Safety and Efficacy of Micro-coring Device for Treatment of Facial Wrinkles and Skin Laxity

Inclusion Criteria: * Fitzpatrick Skin Type 1, 2, or 3 as assessed by Investigator * One or more of the following conditions assessed by Investigator using provided Severity Scales: * Nasolabial fold severity at rest ≥2 and ≤4; * Marionette line prominence at rest ≥2 and ≤4; * Oral commissure drooping at rest ≥2 and ≤4; * Jawline sagging at rest ≥2 and ≤4 . * Moderate-to-Severe wrinkles at rest at least in one of the following areas - the upper lip, chin and cheeks. Exclusion Criteria: * Lesions suspicious for any malignancy or the presence of actinic keratosis, melasma, vitiligo, cutaneous papules/nodules or active inflammatory lesions in the areas to be treated * History of keloid formation or hypertrophic scarring * History of trauma or surgery to the treatment areas in the past 6 months * Scar present in the areas to be treated * Silicone or synthetic material injections in the areas to be treated * Injection of FDA-approved dermal fillers in the past two years * Injection of fat in the past year * History of treatment with dermabrasion, ablative laser, or radiofrequency in the past year * History of treatment with non-ablative laser in the past 6 months * History of treatment with botulinum toxin injections in the areas to be treated within the prior 6 months * Active smokers (0.5 pack/day) or having quit within 3 months prior to treatment * Active, chronic, or recurrent infection * History of compromised immune system or currently being treated with immuno…